A new Northwestern Medicine study published in Nature explains why dopamine neurons are lost in Parkinson’s disease, and demonstrated that a gene therapy targeting the brain’s substantia nigra can substantially boost the benefits of levodopa, an important medication for treating the disease.
A new drug improved management of ulcerative colitis, according to a study published in NEJM.
Northwestern Medicine investigators have discovered that a microtubule regulatory protein inhibits early HIV type 1 (HIV-1) infection.
Northwestern investigators have identified a novel approach to control the hierarchical assembly of protein pathways with DNA, which may facilitate the construction of synthetic protein materials.
Through the Robert J. Havey, MD Institute for Global Health, Feinberg faculty across disciplines are training investigators from Africa, many of whom are enrolled in Feinberg graduate programs, on how to effectively conduct research about diseases currently impacting their home countries.
Human cells use a protein named TBC1D5 to “trap and kill” influenza A viruses inside host cells, but the virus encodes its own protein to disable this defense.
A newly discovered cause of balding in aging male mice could reveal a cause of hair loss in men and women as well, reports a study from Northwestern Medicine scientists.
Northwestern University scientists have received two awards totaling nearly $18 million to address key knowledge gaps in the basic circuit mechanisms that contribute to the development and progression of Parkinson’s disease.
In one of two low-risk randomized clinical trials, financial incentives increased study participation, and the use of financial incentives in both trials were deemed not unethical, according to recent findings.
Coronavirus vaccines and prior coronavirus infections can provide broad immunity against other, similar coronaviruses, paving the way for future universal coronavirus vaccines.